Aggregation chimeras provide evidence of in vivo intercellular correction in ovine CLN6 neuronal ceroid lipofuscinosis (Batten disease)
Lucy A. Barry, Graham W. Kay, Nadia L. MitchelliD, Samantha J. MurrayiD, Nigel P. Jay, David N. PalmeriD
Abstract
The neuronal ceroid lipofuscinoses (NCLs; Batten disease) are fatal, mainly childhood, inherited neurodegenerative lysosomal storage diseases. Sheep affected with a CLN6 form display progressive regionally defined glial activation and subsequent neurodegeneration, indicating that neuroinflammation may be causative of pathogenesis. In this study, aggregation chimeras were generated from homozygous unaffected normal and CLN6 affected sheep embryos, resulting in seven chimeric animals with varied proportions of normal to affected cells. These sheep were classified as affected-like, recovering-like or normal-like, based on their cell-genotype ratios and their clinical and neuropathological profiles. Neuropathological examination of the affected-like animals revealed intense glial activation, prominent storage body accumulation and severe neurodegeneration within all cortical brain regions, along with vision loss and decreasing intracranial volumes and cortical thicknesses consistent with ovine CLN6 disease. In contrast, intercellular communication affecting pathology was evident at both the gross and histological level in the normal-like and recovering-like chimeras, resulting in a lack of glial activation and rare storage body accumulation in only a few cells. Initial intracranial volumes of the recovering-like chimeras were below normal but progressively recovered to about normal by two years of age. All had normal cortical thicknesses, and none went blind. Extended neurogenesis was evident in the brains of all the chimeras. This study indicates that although CLN6 is a membrane bound protein, the consequent defect is not cell intrinsic. The lack of glial activation and inflammatory responses in the normal-like and recovering-like chimeras indicate that newly generated cells are borne into a microenvironment conducive to maturation and survival.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.15
- Field percentile
- 42th percentile
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neonatal brain-directed gene therapy rescues a mouse model of neurodegenerative CLN6 Batten disease
Sophia-Martha kleine Holthaus, Saúl Herranz-Martín, … Robin R. Ali·Human Molecular GeneticsPeer-reviewed·Aug 28, 2019
- Cellular Modeling of CLN6 with IPSC-derived Neurons and Glia
María Gabriela Otero, Jaemin Kim, … Tyler Mark Pierson·bioRxiv·Jan 29, 2024
- Deficiency of the lysosomal protein CLN5 alters lysosomal function and movement
Indranil Basak, Rachel A. Hansen, … Stephanie M. Hughes·BiomoleculesPeer-reviewed·Sep 27, 2021
- Reduction of Neuroinflammation and Seizures in a Mouse Model of CLN1 Batten Disease using the Small Molecule Enzyme Mimetic, N-Tert-Butyl Hydroxylamine.
Zach Fyke, Rachel Johansson, … Akira Yoshii·Molecular Genetics and MetabolismPeer-reviewed·Jul 15, 2024
- The neuronal ceroid lipofuscinosis protein Cln7 regulates neural development from the post-synaptic cell
Kyle J. Connolly, Megan B O'Hare, … Guy Tear·bioRxiv·Feb 19, 2019
- CLN3 deficiency leads to neurological and metabolic perturbations during early development
Ursula Heins-Marroquin, Randolph R. Singh, … Carole L. Linster·Life Science AlliancePeer-reviewed·Jan 9, 2024